Omid Seidizadeh: Strategies to Guide The 2nd 100 years of VWD Care and Research
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn about a recent article he and his colleagues co-authored, published in RPTH, adding:
”In this Viewpoint, we discuss the striking gap between the expected prevalence of von Willebrand disease (VWD) and diagnosed cases, the global burden and consequences of underdiagnosis, the reasons why underdiagnosis persists after a century, and ultimately propose strategies to guide the second 100 years of VWD care and research.”
Title: Beyond a century of discovery: the global and persistent burden of underdiagnosis in von Willebrand disease
Authors: Omid Seidizadeh, Rezan Abdul-Kadir, Pier Mannuccio Mannucci, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic